Skip to Main Content

Paper Details

Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia.
Nat Commun
16
2022
17 gene, AML, LSC, LSC17, LSC47, RNA, acute myeloid leukemia, leukemia, leukemia stem cell signature, pediatric, stem cell
Author NameAffiliation
Rhonda E RiesFred Hutchinson Cancer Research Center
Rhonda E RiesFred Hutchinson Cancer Research Center
Erin L CrowgeyNemours Center for Cancer and Blood Disorders and Alfred I. DuPont Hospital for Children
Erin L CrowgeyNemours Center for Cancer and Blood Disorders and Alfred I. DuPont Hospital for Children
Yanling LiuSt. Jude Children's Research Hospital
Yanling LiuSt. Jude Children's Research Hospital
Richard AplencChildren's Hospital of Philadelphia
Richard AplencChildren's Hospital of Philadelphia
Edward A KolbNemours Center for Cancer and Blood Disorders and Alfred I. DuPont Hospital for Children
Jeffery M KlcoSt. Jude Children's Research Hospital
Xiaotu MaSt. Jude Children's Research Hospital
Xiaotu MaSt. Jude Children's Research Hospital
Todd A AlonzoUniversity of Southern California
Todd A AlonzoUniversity of Southern California
Timothy J TricheVan Andel Research Institute
Timothy J TricheVan Andel Research Institute
Soheil MeshinchiFred Hutchinson Cancer Research Center
Soheil MeshinchiSeattle Children's Hospital, University of Washington
Soheil MeshinchiFred Hutchinson Cancer Research Center
Soheil MeshinchiSeattle Children's Hospital, University of Washington
  • 1 - 20

Datasets